Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients.
Features of Individualized Medication Guidance for Prostate Cancer DiagnosisTargeted therapy-Including SNV, InDel, CNV and gene rearrangement, comprehensively guide targeted drug use.
Immunotherapy-Detect TMB and MSI indicators, as well as positive and negative immune-related genes, provide information to guide immunosuppressive therapy.
Chemotherapy- Detect chemotherapeutic drug loci associated with prostate cancer, suggesting sensitivity and toxic side effects of chemotherapeutic drugs.
Hereditary risk assessment- Covering HRR pathway genes, suggesting pathogenic and suspected pathogenic variants, guiding PARP inhibitor therapy, and suggesting genetic risk based on family tumor history and other information.
Applicable Population of Individualized Medication Guidance for Prostate Cancer Prognosis, Prostate Cancer Prevention, Prostate Cancer Therapy
Prostate cancer patients who have relapsed, drug-resistant problem.
Prostate cancer patients who have been diagnosed with prostate cancer, and need liquid biopsy for targeted therapy and immunotherapy.
Late-stage newly diagnosed prostate cancer patients who need targeted therapy and immunotherapy.
If you want to know more details of chemotherapy for prostate cancer, please visit our website.
As an ivd in vitro diagnosticcompany, we can offer sorts of ivd in vitro diagnosticequipment for sale, if you are interested, please leave us a message.
Send product request
Other supplier products
 |
CMA Detection | The CMA testof CapitalBio Technology uses Affymetrix GeneChip System 3000Dx and CytoScan 750K chip, it can not only provide accurate detection of c... |
 |
Fully Integrated Platform for COVID-19 | Fully Integrated Platform for COVID-19 The employment of a single system to execute all functions that are capable of being accomplished by the co... |
 |
CapitalBio® Microarray Scanner LuxScan™10K/D | CapitalBio® Microarray Scanner LuxScan™10K/D, a novel optical system design based on the laser confocal principle, improves detection sen... |
 |
CapitalBio® Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer RTisochip™-A | CapitalBio® Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer RTisochip™-A and the supporting dish chip are a new platform... |
 |
Clinical WES | At present, there are more than 20,000 human genes have been discovered, with a total of more than 180,000 exons. Genes are composed of exons and i... |
Same products
 |
Metal Insulated Composite Panel Systems | Seller: Zhejiang Leboom Energy Conservation Technology Co., Ltd | Metal Insulated Composite Panel Systems The system is composed of fire-resistant composite metal... |
 |
AluzincMg-Al-Zn Alloy Composite Panel Systems | Seller: Zhejiang Leboom Energy Conservation Technology Co., Ltd | AluzincMg-Al-Zn Alloy Composite Panel Systems Introducing magnesium aluminum zinc composite pane... |
 |
Aluminium Insulated Composite Panel Systems | Seller: Zhejiang Leboom Energy Conservation Technology Co., Ltd | Aluminium Insulated Composite Panel Systems This system features composite panels manufactured i... |
 |
3D Aluminium Composite Panel Systems | Seller: Zhejiang Leboom Energy Conservation Technology Co., Ltd | 3D Aluminium Composite Panel Systems The 3D Aluminium Composite Panelutilizes aluminum alloy she... |
 |
Calcium Silicate Board Integrated Exterior Wall Insulation | Seller: Zhejiang Leboom Energy Conservation Technology Co., Ltd | Calcium Silicate Board Integrated Exterior Wall Insulation and Decoration Panel Leboomoffers hig... |
